or Try an Advanced Search...

    Monogenic Diseases Stocks List

    Symbol Grade Name % Change
    SGMO C Sangamo BioSciences, Inc. -4.65
    TSHA D Taysha Gene Therapies, Inc. -9.25
    RXRX F Recursion Pharmaceuticals, Inc. -10.64
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biotechnology Life Sciences Monogenic Blastoma Cell Product Deficiency Deficiency Syndrome Dow Agrosciences Drug Discovery Emerging Technologies Gangliosidosis Gene Therapy Glioblastoma Gm2 Gangliosidoses Gm2 Gangliosidosis Health Care Health Sciences Hemoglobin Hemoglobinopathies Hemophilia

    Related ETFs - A few ETFs which own one or more of the above listed Monogenic Diseases stocks.

    Symbol Grade Name Weight
    ARKG F ARK Genomic Revolution Multi-Sector ETF 7.42
    ARKK A ARK Innovation ETF 2.15
    QQQS C Invesco NASDAQ Future Gen 200 ETF 1.55
    CNCR F Loncar Cancer Immunotherapy ETF 1.36
    IBRN C iShares Neuroscience and Healthcare ETF 1.34
    View all Monogenic Diseases ETFs...
    Compare ETFs
    Compare ARKG to IBRN Compare CNCR to IBRN Compare QQQS to IBRN

        Monogenic Diseases Stocks Recent News

        Date Stock Title
        Nov 15 RXRX Nvidia Discloses Stake In Applied Digital, Keeps Arm, SoundHound Stakes
        Nov 15 TSHA Taysha Gene Therapies Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
        Nov 15 SGMO Sangamo Therapeutics Third Quarter 2024 Earnings: Beats Expectations
        Nov 14 TSHA Q3 2024 Taysha Gene Therapies Inc Earnings Call
        Nov 14 TSHA Why DLocal Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
        Nov 14 TSHA Taysha Gene Therapies Inc (TSHA) Q3 2024 Earnings Call Highlights: Clinical Progress and ...
        Nov 14 TSHA Taysha Gene Therapies, Inc. (TSHA) Q3 2024 Earnings Call Transcript
        Nov 13 TSHA Taysha Gene Therapies, Inc. (TSHA) Reports Q3 Loss, Lags Revenue Estimates
        Nov 13 TSHA Taysha Gene Therapies GAAP EPS of $1.78 beats by $1.87, revenue of $1.78M beats by $0.13M
        Nov 13 TSHA Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update
        Nov 13 SGMO Q3 2024 Sangamo Therapeutics Inc Earnings Call
        Nov 13 RXRX Recursion and Exscientia Shareholders Approve the Proposed Combination
        Nov 13 TSHA Earnings Scheduled For November 13, 2024
        Nov 13 SGMO Sangamo Therapeutics Inc (SGMO) Q3 2024 Earnings Call Highlights: Strategic Advances and ...
        Nov 13 SGMO Sangamo Therapeutics, Inc. (SGMO) Q3 2024 Earnings Call Transcript
        Nov 12 SGMO Sangamo Therapeutics files for mixed shelf offering
        Nov 12 SGMO Sangamo Therapeutics (SGMO) Tops Q3 Earnings and Revenue Estimates
        Nov 12 SGMO Sangamo Therapeutics Q3 beats propel stock 5% higher
        Nov 12 RXRX Recursion Announces the Release of OpenPhenom-S/16 in Google Cloud’s Model Garden
        Nov 12 SGMO Sangamo: Q3 Earnings Snapshot
        Related Industries: Biotechnology
        Related Stock Lists: Biotechnology Life Sciences Monogenic Blastoma Cell Product Deficiency Deficiency Syndrome Dow Agrosciences Drug Discovery Emerging Technologies Gangliosidosis Gene Therapy Glioblastoma Gm2 Gangliosidoses Gm2 Gangliosidosis Health Care Health Sciences Hemoglobin Hemoglobinopathies Hemophilia
        Monogenic Diseases

        Monogenic diseases are genetic disorders caused by a mutation in a single gene. These diseases can be inherited from a parent or can occur spontaneously. Examples of monogenic diseases include cystic fibrosis, Huntington's disease, and sickle cell anemia.

        Browse All Tags